Iron, Cobalt, Nickel, Vanadium, Molybdenum, Or Palladium Patents (Class 424/646)
-
Publication number: 20100278940Abstract: A composition comprising at least 15%, by weight, of calcium derived from a rhodolith coralline algae; magnesium; strontium; vanadium; vitamin K; and vitamin D3.Type: ApplicationFiled: April 27, 2010Publication date: November 4, 2010Applicants: HL DISTRIBUTION COMPANYInventors: Dean Neuls, Marcos Antonio Dias Neves
-
Publication number: 20100278941Abstract: The present invention relates to methods and compounds for regulating or enhancing erthropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.Type: ApplicationFiled: July 12, 2010Publication date: November 4, 2010Inventors: Stephen J. Klaus, Christopher J. Molineaux, Thomas B. Neff, Volkmar Guenzler-Pukall, Ingrid Langsetmo Parobok, Todd W. Seeley, Robert C. Stephenson
-
Publication number: 20100272827Abstract: Embodiments provide devices, systems and methods for the transdermal delivery of chelated compounds. One embodiment provides a method for the iontophoretic transdermal delivery of a chelated iron complex for the treatment of anemia. A first patch comprising an active electrode and a chelated iron complex is applied to the skin; a second patch containing an electrode is also applied. An electrical current is then delivered to the skin from the active electrode. The chelated complex is transported across the skin via electromotive force from the current, with the iron being substantially chromogenically unreactive with the skin during transport so that there is little or no tattooing of the skin due to the formation of insoluble oxidative products. The complex is then dissociated by phagocytosis or related process to release the iron where it may be bound by transferrin or ferritin and carried to other sites for storage or metabolic use.Type: ApplicationFiled: July 7, 2009Publication date: October 28, 2010Inventors: Mir Imran, Mir Hashim, Sanjay Patel, Ronald J. Berenson
-
Publication number: 20100272789Abstract: An external medicine includes an active hydrogen generating agent, which generates active hydrogen by bringing multiple agents into contact, and/ or an active hydrogen generating agent, which activates generated hydrogen molecules.Type: ApplicationFiled: January 5, 2009Publication date: October 28, 2010Inventors: Bunpei Satoh, Youhei Satoh, Fumitake Satoh
-
Publication number: 20100266647Abstract: Compositions comprising a gel system made from a combination of a fractal network of nanoparticles and translucent macroscopic particles, titanium dioxide and other color pigments is disclosed. The compositions are capable of forming an effective film on the biological surface such as skin to blurring fine lines and wrinkles while retaining a natural look of the skin as a consequence of synergy between the fractal particles, the macroscopic particles, titanium dioxide and color pigments. Also disclosed methods for their use.Type: ApplicationFiled: November 14, 2008Publication date: October 21, 2010Applicant: AVON PRODUCTS, INC.Inventors: Ajay G. Dingley, Michael J. Fair, John R. Glynn, JR., Giovana A. Sandstrom
-
Publication number: 20100266644Abstract: The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.Type: ApplicationFiled: May 25, 2010Publication date: October 21, 2010Applicant: LUITPOLD PHARMACEUTICALS, INC.Inventors: Mary Jane Helenek, Marc L. Tokars, Richard P. Lawrence
-
Patent number: 7816404Abstract: A highly water soluble ferric pyrophosphate citrate chelate useful for treating iron deficiency contains 2% or less phosphate by weight. These chelate compositions are easily milled and/or processed into dosage forms using conventional techniques, and are expected to exhibit advantageous biocompatibility as compared to conventional soluble ferric pyrophosphates, ferric salts, ferric polysaccharide complexes and ferrous salts.Type: GrantFiled: June 12, 2008Date of Patent: October 19, 2010Assignee: Rockwell Medical Technologies, Inc.Inventor: William S. McCall, Jr.
-
Patent number: 7811609Abstract: Cobalt salts have been found to be particularly effective against H. pylori and may therefore be used to treat gastrointenstinal infection with this bacteria. The cobalt salts have the advantage of showing a good degree of selectivity for H. pylori over other Gram positive and Gram negative bacteria. Treatment with the cobalt salts may be carried out at the same time as conventional treatment with an antibiotic and/or a proton pump inhibitor.Type: GrantFiled: May 24, 2001Date of Patent: October 12, 2010Assignee: Pfylori LimitedInventors: Sylvaine Franciose Aline Bruggraber, Jonathan Joseph Powell
-
Publication number: 20100247611Abstract: The present disclosure describes compositions operable for releasing nitric oxide under photochemical conditions. The compositions include a titanium dioxide nanomaterial and a nitric oxide-releasing compound deposited on the titanium dioxide nanomaterial that is operable to release nitric oxide under photochemical conditions. Titanium dioxide nanomaterials include, for example, titanium dioxide nanotubes. To facilitate the photochemical release of nitric oxide, some embodiments of the compositions further include a semiconductor that is deposited on the titanium dioxide nanotubes. Both the semiconductor and the nitric oxide-releasing compound may be deposited on the interior surface, exterior surface, or both of the titanium dioxide nanotubes. A polymer may wrap the titanium dioxide nanotubes to protect the nitric oxide-releasing compounds from moisture. Also disclosed herein are methods for producing such compositions and medical devices obtained therefrom.Type: ApplicationFiled: March 30, 2010Publication date: September 30, 2010Applicant: Board of Regents, The University of Texas SystemInventors: Kenneth J. Balkus, JR., Chalita Ratanatawanate
-
Publication number: 20100247489Abstract: The present invention relates to a composition comprising one or more minerals selected from the group consisting of selenium, molybdenum or tungsten, which is carried out galenically or chemically in a way that the mineral or minerals are released completely or in part, just before, during or shortly after arrival at the large intestine, and their use in the manufacture of a medicament for administering to a mammal for the prevention or reduction of gas formation in the colon thus conditioned abdominal complaints, particularly bloatings, meteorism or abdominal cramps. Furthermore, the invention relates to a procedure for the isolation of acetogenic and butyrogenic bacterial strains that are suitable for therapeutic purposes outlined above.Type: ApplicationFiled: December 21, 2007Publication date: September 30, 2010Inventor: Roland SAUR-BROSCH
-
Publication number: 20100239663Abstract: This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/or amino groups. The compound(s) are mixed with a non-toxic carrier that effects sustained release of said compound(s) in the gastrointestinal tract. This invention relates also to food additives and food compositions and packages comprising the composition.Type: ApplicationFiled: May 22, 2007Publication date: September 23, 2010Applicant: BIOHIT OYJInventors: Osmo Suovaniemi, Ville Salaspuro, Martti Marvola, Mikko Salaspuro
-
Publication number: 20100233269Abstract: A process for mineralizing a particulate organic material includes providing particles of a non-porous, swellable organic material, and contacting the particles with a solution containing at least one cation and a solution containing at least one anion, thereby obtaining the mineralized particulate organic material.Type: ApplicationFiled: March 12, 2010Publication date: September 16, 2010Applicants: Baxter International, Inc., Baxter Healthcare S.A.Inventors: Katarzyna Gorna, Andreas Goessl
-
Publication number: 20100226873Abstract: A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.Type: ApplicationFiled: March 8, 2010Publication date: September 9, 2010Applicant: BIOLIFE, L.L.C.Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Publication number: 20100227001Abstract: A method of delivering nutrients for bariatric patients comprising the sublingual administration of a B-complex vitamin composition and ingesting a liquid, water-soluble multi-vitamin complex orally at approximately the same time. The liquid multi-vitamin is comprised of a plurality of compounds from the group of Vitamin A, Vitamin C, Vitamin D and Vitamin E. After administering the Vitamin B complex and the liquid multi-vitamin, a solid vitamin formulation comprising at least two compounds from the group of iron, zinc, selenium, copper, chromium, Vitamin K, and manganese is ingested orally. A protein solution comprising proteins broken down into small peptide chains, calcium, and fiber may also be delivered orally to the bariatric patient in a liquid form. The method may be repeated once or twice daily. The method of the invention maximizes delivery and absorption of nutrients to the bariatric patient and the tolerance and speed of delivery.Type: ApplicationFiled: March 5, 2009Publication date: September 9, 2010Inventor: SILVIA DEMETER
-
Publication number: 20100226900Abstract: The invention provides compositions and methods for preventing and treating osteochondrosis and lameness by administration of supplemental boron containing compounds to animals and humans. The supplemental boron containing compounds are provided in animal feed compositions or as supplements for animal feed. Also provided by this invention are animal feed compositions that are supplemented with boron containing compounds and which have reduced phosphorus content. The invention also provides a method for decreasing the amount of phosphorus excreted by an animal, a method of increasing the efficiency of absorption of phosphorus by an animal, a method of reducing environmental phosphorus pollution by administering supplemental boron to the animal. The invention also provides a method of reducing pre-weaning mortality in an animal by feeding pregnant, nursing or lactating animals by administering supplemental boron containing compounds.Type: ApplicationFiled: December 6, 2006Publication date: September 9, 2010Applicant: U.S. Borax Inc.Inventor: Edgar W. Johnson
-
Patent number: 7790202Abstract: A multi-purpose skin composition which functions as a sunscreen, an anti-perspirant, an insect/pest repellant and/or an antiseptic is disclosed. In some illustrative embodiments, the multi-purpose skin composition includes a powdered repellent formulation having a substantially homogenous powdered mixture including corn starch powder, zinc oxide powder, peppermint powder, basil powder, rosemary powder, eucalyptus powder, copper mica powder and silica powder spheres. In other illustrative embodiments, the multi-purpose skin composition includes a powdered relief formulation having a substantially homogenous powdered mixture comprising corn starch powder, lavender powder, peppermint powder, eucalyptus powder and silica powder spheres.Type: GrantFiled: April 9, 2007Date of Patent: September 7, 2010Inventor: Helen D. Martell
-
Publication number: 20100215770Abstract: The present invention relates to mixed metal compounds having pharmaceutical activity, especially as phosphate binders. It also extends to methods of manufacture of those compounds, as well as to pharmaceutical compositions containing such compounds. It further relates to their pharmaceutical use. In particular, the present invention relates to use of compounds of Formula (I): MII1-aMIIIa wherein M is at least one bivalent metal (i.e. with two positive charges); M1 is at least one trivalent metal (i.e. with three positive charges); and 1>a>0.4.Type: ApplicationFiled: October 15, 2008Publication date: August 26, 2010Inventors: Maurice Sydney Newton, Alexis John Toft, Nigel Peter Rhodes
-
Publication number: 20100215767Abstract: Disclosed are: a skin whitening agent including, as an active ingredient, a complex of carbonic acid and/or bicarbonic acid, a metal and an LF, a decomposition product of the complex, or a complex of carbonic acid and/or bicarbonic acid, a metal and a decomposition product of an LF; and a food, beverage, feed or cosmetic including the skin whitening agent. The skin whitening agent can be ingested safely on a daily basis, and exhibits an excellent skin whitening effect.Type: ApplicationFiled: May 22, 2008Publication date: August 26, 2010Applicant: SNOW BRAND MILK PRODUCTS CO., LTD.Inventors: Tatsuya Watanabe, Ken Kato, Hiroshi Ueno, Yuko Haruta, Noriko Ueda, Toshimitsu Yoshioka
-
Publication number: 20100203152Abstract: There is provided use of a mixed metal compound in the manufacture of medicament for neutralising or buffering stomach acid, wherein the mixed metal compound contains at least one trivalent metal selected from iron (III) and aluminium and at least one divalent metal selected from of magnesium, iron, zinc, calcium, lanthanum and cerium, wherein (A) the mixed metal compound is of formula (I): MII1-aMIIIaObAn-c.zH2O (I) where MII is the at least one bivalent metal; MIII is the at least one trivalent metal; An- at least one n-valent anion; 2+a=2b+?cn and ?cn<0.9a, and z is 2 or less, and/or (B) the mixed metal compound is provided in the form of a granular material comprising (i) at least 50% by weight, based on the weight of the granular material, of the mixed metal compound (ii) from 3 to 12% by weight, based on the weight of the granular material, of non-chemically bound water, and (iii) no greater than 47% by weight based on the weight of the granular material of excipient.Type: ApplicationFiled: July 24, 2008Publication date: August 12, 2010Applicant: Ineos Healthcare KimitedInventors: Maurice Sydney Newton, James David Morrison, Ruth Diane Pennell, Nigel Peter Phodes, Alexis John Toft
-
Publication number: 20100203126Abstract: The present invention relates to a multi-layered vitamin/mineral complex tablet having enhanced stability of ubidecarenone. The present invention is characterized in that ubidecarenone is contained in a first layer, and ingredients decreasing the stability of ubidecarenone are contained in an additional layer separated from the first layer. The method is a convenient process, and the formulation prepared by the method can maintain a high content of ubidecarenone during long-term storage, thereby providing a simultaneous intake of ubidecarenone and nutritional ingredients such as various vitamins.Type: ApplicationFiled: July 11, 2008Publication date: August 12, 2010Inventors: Jong-Woo Park, Jin-Woo Han, Yae-Young Choi
-
Publication number: 20100203159Abstract: The invention provides a metal component absorption enhancer which enhances the absorption of at least one metal component selected from the elements belonging to the groups 2 to 12 in the third to fourth periods when a plant grows. An absorption enhancer of at least one metal component selected from the elements belonging to the groups 2 to 12 in the third to fourth periods in a plant, which comprises 5-aminolevulinic acid or a derivative thereof represented by the following general formula (1), or a salt thereof as an active ingredient: R2R1NCH2COCH2CH2COR3??(1) wherein R1 and R2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; R3 represents a hydroxyl group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group, and is used for performing a treatment with 0.Type: ApplicationFiled: September 5, 2007Publication date: August 12, 2010Applicant: COSMO OIL CO., LTD.Inventors: Naohisa Tachiya, Shigeyuki Funada, Masahiro Ishizuka
-
Publication number: 20100189806Abstract: Methods of growing and harvesting multiple species of phytoplankton are disclosed herein. The method generally includes four steps, namely: (1) collecting phytoplankton seawater containing multiple species of naturally-occurring phytoplankton directly from a source of seawater; (2) adding nutrients to the phytoplankton seawater to proliferate the multiple species of naturally-occurring phytoplankton to a predetermined density; (3) separating the multiple species of naturally-occurring phytoplankton from the phytoplankton seawater to form a phytoplankton concentrate; and (4) collecting the phytoplankton concentrate such that the collected phytoplankton of the phytoplankton concentrate remain in a substantially intact cellular state.Type: ApplicationFiled: October 21, 2009Publication date: July 29, 2010Inventors: Margaret Harper, Arturo Ramirez
-
Publication number: 20100191040Abstract: Methods are provided for activating dormant ovarian primordial follicles in a mammal to promote development to preovulatory follicles.Type: ApplicationFiled: January 25, 2010Publication date: July 29, 2010Inventors: Aaron J.W. Hsueh, Jing Li
-
Patent number: 7763283Abstract: Biocompatible materials that have the ability to release nitric oxide (NO) in situ at the surface-blood interface when in contact with blood. The materials which may be polymers (e.g., polyurethane, poly(vinyl chloride), silicone rubbers), metals, such as stainless steel, carbon, and the like are provided with biocatalysts or biomimetic catalysts on their surface that have nitrite, nitrate, and/or nitrosothiol-reducing capability. Illustratively, the catalysts are adsorbed or immobilized at the surface of the material. The catalysts can act on endogenous nitrite, nitrate, or nitrosothiols within the blood creating a local increase in the NO levels at the surface of the material. An illustrative enzymatic biocatalyst is mammalian xanthine oxidase. In another illustrative embodiment, a biomimetic catalyst is a copper (Cu(II)-ligand complex, e.g. dibenzo[e,k]-2,3,8,9-tetraphenyl-1,4,7,10-tetraaza-cyclododeca-1,3,7,9-tetraene. In some cases, lipophilic salts of nitrite/nitrate (e.g.Type: GrantFiled: September 19, 2006Date of Patent: July 27, 2010Assignees: The Regents of The University of Michigan, Accord Biomaterials, Inc.Inventors: Melissa M. Batchelor, Bong Kyun Oh, Mark E. Meyerhoff
-
Patent number: 7758897Abstract: The invention relates to a process for preparing metal complexes containing carbene ligands by reacting metal compounds with ligand precursors II and/or III and to the use of the thus obtained metal complexes as catalysts.Type: GrantFiled: October 24, 2003Date of Patent: July 20, 2010Assignee: Evonik Oxeno GmbHInventors: Dirk Roettger, Ralf Jackstell, Matthias Beller
-
Patent number: 7758899Abstract: A pharmaceutical composition is provided comprised of a physiologically acceptable source of assimilable copper, a source of salicylic acid or a physiologically acceptable derivative thereof, and vitamin C.Type: GrantFiled: December 3, 2004Date of Patent: July 20, 2010Inventor: John Carter
-
Patent number: 7758898Abstract: The present invention relates generally to the field of prophylaxis and therapy for inflammatory and/or fibrotic diseases which include responses to injuries. In particular, the present invention is related to agents that can bind or complex copper such as thiomolybdate, and to the use of these agents in the prevention and treatment of inflammatory and/or fibrotic diseases.Type: GrantFiled: May 29, 2007Date of Patent: July 20, 2010Assignee: The Regents of the University of MichiganInventor: George J. Brewer
-
Publication number: 20100178357Abstract: The present invention relates to the use of combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and an oxidizing agent, for eradicating, eliminating or reducing aquatic organisms in ballast water or bilge water whereby 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and the oxidizing agent are in respective proportions to provide a synergistic effect against fouling organisms. Suitable oxidizing agents are e.g.Type: ApplicationFiled: August 6, 2007Publication date: July 15, 2010Inventor: Tony Mathilde Jozef Kempen
-
Publication number: 20100178356Abstract: This invention relates to a method for enhanced sanitation and oxidation of aqueous solutions at aquatic facilities. The method provides a means for the in-situ generation of chlorine dioxide from dilute solutions of chlorite anions at near neutral pH, and enhanced inactivation rates of microbiological organisms including cryptosporidium.Type: ApplicationFiled: July 23, 2009Publication date: July 15, 2010Inventor: Roy W. Martin
-
Publication number: 20100178361Abstract: There are provided an iron composition including a milk protein and an iron preparation, which is stable in the presence of a substance having a property of releasing iron from the composition or reducing the released iron, and foods or drinks, animal feeds, and medicines blended with the iron composition. A milk protein such as skim milk is blended into an iron preparation, thereby producing the iron composition which is stable in the presence of a substance having a property of releasing iron from the composition or reducing the released iron (e.g., vitamin C or citric acid).Type: ApplicationFiled: March 23, 2010Publication date: July 15, 2010Applicant: SNOWBRAND MILK PRODUCTS CO., LTD.Inventors: Noriko UEDA, Ken KATO, Miyako TANAKA, Yuji KAKEHI, Kaoru SATO, Toshimitsu YOSHIOKA
-
Patent number: 7754197Abstract: A method for reducing odor is provided. The method comprises forming a coordination complex between a transition metal and a polydentate compound, and contacting the coordinated complex with an odorous compound. The transition metal provides one or more active sites for capturing the odorous compound. In some embodiments, the polydentate compound may be a polyalkylimine, such as polyethyleneimine, polypropyleneimine, or a dendrimer thereof.Type: GrantFiled: October 16, 2003Date of Patent: July 13, 2010Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Bin Wu, Kevin P. McGrath, Jaeho Kim, Bao Trong Kim, Sharon Linda Greene, Yanbin Huang, Kaiyuan Yang
-
Publication number: 20100173012Abstract: A method of treating an apple orchard to reduce infection of the apple orchard by Venturia inaequalis by administering EARTHTEC® or a derivative of EARTHTEC®. A method of reducing sporulation of V. inaequalis by administering EARTHTEC® or a derivative of EARTHTEC®. A method of reducing the dispersal of ascospores from V. inaequalis-infected apple debris in orchards by administering EARTHTEC® or a derivative of EARTHTEC®.Type: ApplicationFiled: December 3, 2009Publication date: July 8, 2010Inventors: Frances Trail, Russell J. Rodriguez
-
Publication number: 20100166682Abstract: A composition comprising mineral water and a chelating agent present in an amount sufficient to maintain all of the minerals in the water in solution. The mineral water is preferably obtained from Mount Clemens, Mich., US, and is preferably chelated with an ammonium and/or a sodium salt of an acid selected from the group consisting of ethylenediaminetetraacetic acid, nitrilotetraacetic acid, ?-alaninediacetic acid, ethylenediaminosuccinic acid, aminotrimethylenephosphoric acid, serinediaacetic acid, asparaginediacetic acid, methylgylcinediacetic acid and mixtures thereof. The resultant chelated mineral water may be combined with a cosmetically acceptable skin-conditioning agent and a cosmetically acceptable topical carrier, thereby resulting in a cosmetic composition that will confer beneficial effects on the skin, e.g., softening, hydrating and healing effects.Type: ApplicationFiled: April 19, 2008Publication date: July 1, 2010Applicant: GEOLOGIX, INC.Inventor: Stephen Musumeci
-
Publication number: 20100166818Abstract: A laundry additive such as a fabric dryer sheet formed of a flexible substrate contains an insecticidally effective amount of an insecticide, preferably a pyrethrum, in an amount between about 0.05 and about 10 grams per square foot. Alternatively, the insecticide may be included as a component in a rinse-cycle laundry additive. Such laundry additives are appropriate for use by institutions such as hotels, cruise ships, and nursing homes, hospitals, and shelters in the prevention and control of bed bugs.Type: ApplicationFiled: November 17, 2009Publication date: July 1, 2010Inventor: Stevan L. Troutman
-
Publication number: 20100151049Abstract: The subject invention concerns methods for preparing alkaline earth ferrates and the preparation of hemostatic compositions from alkaline earth ferrates. In one embodiment, the alkaline earth ferrate is strontium ferrate. In one embodiment, methods of the invention comprise heat treating mixtures of alkaline earth oxides and/or peroxides with iron oxides, such as hematite or magnetite. The subject invention also concerns hemostatic compositions produced using metallic oxides that are reacted with alkaline earth oxides and/or peroxides and the methods used to produce the hemostatic compositions.Type: ApplicationFiled: November 30, 2009Publication date: June 17, 2010Applicant: Biolife, LLCInventors: John Alfred Thompson, John Hen
-
Publication number: 20100151044Abstract: A method of using a seawater-based isoosmotic ionic solution for manufacturing a medical device for administering said solution by nasal spray or mist to patients in the remission phase of the common cold or flu syndrome, or to patients suffering from the common cold or flu syndrome, to prevent and/or treat complications of the common cold or flu syndrome is described.Type: ApplicationFiled: April 25, 2008Publication date: June 17, 2010Applicant: LABORATOIRE DE LA MERInventors: Anne Beaulieu, Francois Andro
-
Publication number: 20100143333Abstract: The present invention relates to a method for treating a subject having or at risk of a diabetes-related disorder. In a preferred embodiment, the method involves increasing the level or activity of Hypoxia Induced Factor 1 (HIF-1 ?) in pancreatic-?-cells or insulin-sensitive tissues in the subject by administering to the subject an inhibitor of a protein that decreases the level or activity of HIF-1?. The present invention also relates to a method of transplanting pancreatic islet cells in a subject.Type: ApplicationFiled: November 20, 2007Publication date: June 10, 2010Applicant: Garvan Institute of Medical Research C/-St. Vincent's HospitalInventor: Jenny Gunton
-
Publication number: 20100136088Abstract: In a tampon device (100) for insertion into the vulva, with a packing (110) of absorbent substance for taking up menstrual fluid, problems associated with menstruation, such as painful muscle tension and cramps in the area of the vulvar musculature, are alleviated or eliminated by the fact that a magnetic substance (120) interacting with the earth's magnetic field is integrated into the packing (110).Type: ApplicationFiled: June 23, 2007Publication date: June 3, 2010Inventor: Christian Sulger
-
Publication number: 20100119619Abstract: A personal care composition in the form of an aqueous gel may comprise an alpha-hydroxy acid, wherein the pH of the composition is less than about 4.5. The personal care composition comprises a gelling agent and an aqueous solvent. The personal care composition further comprises particulates and an effective amount of suspension agent to suspend the particulates. The personal care composition exhibits a consumer desired viscosity and translucency.Type: ApplicationFiled: October 28, 2009Publication date: May 13, 2010Inventors: Susan Adair GRIFFITHS-BROPHY, Dennis Eugene Kuhlman
-
Patent number: 7713554Abstract: The subject invention provides a process and apparatus for making “enhanced water” that is uniquely suitable for improving circulation, hydration and insulin usage with diabetics. Thus, in a preferred embodiment, the invention provides methods for the treatment and/or prevention of diabetes as well as the prevention or delay in development of diabetes-related complications, conditions or diseases.Type: GrantFiled: March 1, 2005Date of Patent: May 11, 2010Assignee: Wellness Enterprises, LLCInventor: Harusuke Naito
-
Publication number: 20100111920Abstract: A therapeutic composition for vaginal administration based on the generation of a biocidal anion by an enzymatic reaction catalyzed by a peroxidase. The peroxide utilized by the peroxidase enzyme can be endogenous or can be generated by the action of an oxidase enzyme on a suitable substrate. Therapeutic compositions according to the present invention are useful for the treatment of vaginal diseases and conditions, including bacterial and fungal infections.Type: ApplicationFiled: September 28, 2007Publication date: May 6, 2010Inventors: Michael Pellico, Rajvinder Kaur Atwal
-
Publication number: 20100098776Abstract: The invention relates to soap-based liquid body and facial wash compositions using high solvent, low water compositions and incompletely neutralized fatty acids to help structure the compositions, all in combination with modified benefit agents, enhanced deposition of antimicrobial agents is obtained.Type: ApplicationFiled: October 21, 2008Publication date: April 22, 2010Applicant: CONOPCO, INC., D/B/A UNILEVERInventors: Joseph Oreste Carnali, Pravin Shah, Qiang Qiu, Anthony John Weir
-
Patent number: 7692012Abstract: Novel Vanadium compounds are described as well as their use as inhibitors of phosphatases, particularly inositol phosphatases, The use of the compound in the treatment of nerodegenerative diseases is also described.Type: GrantFiled: December 6, 2004Date of Patent: April 6, 2010Assignee: Imperial College Innovations LimitedInventors: Rudiger Woscholski, Erika Rosivatz, Ramon Vilar
-
Publication number: 20100080856Abstract: A composition and a method for administering the composition to a patient in order to accelerate wound healing, particularly postoperative wound healing. The composition, which essentially comprises ornithine ?-ketoglutarate, is water-soluble and formulated for oral administration in single-dose packets. The method for using the composition for promoting wound healing includes the step of administering the composition to a patient preoperatively as well as-postoperatively in accordance with a prescribed protocol. The composition may be customized to include one or more additional agents that are effective for promoting nutritional health and/or treating a particular medical problem. The composition may also be taken daily by athletes to minimize the healing time of closed wounds such as muscle or tendon tears that occur during participation in sports, even when the symptoms of such injury are subclinical.Type: ApplicationFiled: September 26, 2008Publication date: April 1, 2010Inventor: Peter D. Costantino
-
Publication number: 20100074928Abstract: Cosmetic composition providing a high coverage of skin while retaining a natural skin appearance comprising iron oxide particles having an average surface area from 30 m2/g to 150 m2/g, iron-containing titanium dioxide particles having an average surface area from 1 m2/g to 30 m2/g and comprising from 1% to 15% iron by weight of the titanium dioxide, and a cosmetically acceptable carrier and its use as a foundation and/or as a composition to correct skin discoloration surrounding the eye.Type: ApplicationFiled: July 1, 2009Publication date: March 25, 2010Inventors: Russell Philip Elliott, Joanne Watson
-
Publication number: 20100074968Abstract: The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method for treatment and prophylaxis of cancer.Type: ApplicationFiled: November 30, 2009Publication date: March 25, 2010Inventor: Thomas TALLBERG
-
Publication number: 20100068297Abstract: Disclosed herein are antimicrobial compositions comprising an effective concentration of a metal salt combined with a plant extract. In some embodiments the composition comprises a copper salt and/or an iron salt and/or a nickel salt and/or a cobalt salt; and an extract of a plant selected from a group consisting of Punka granatum, Viburnum plicatum, Camellia sinensis, and Acer spp. The invention extends to uses of such compositions as medicaments, and to methods of treating microbial infections. The invention extends to methods for preventing microbial infections by coating objects and surfaces with the compositions.Type: ApplicationFiled: December 6, 2007Publication date: March 18, 2010Applicant: NATURE THERAPEUTICS LIMITEDInventor: Declan Naughton
-
Publication number: 20100068301Abstract: Disclosed herein are compositions and compounds that combine an inhibitor of 5-lipoxygenase activating protein (FLAP) and a modulator of NO levels in a mammal. The NO modulator can be an agent that induces the production of NO in a mammal, or can be an agent that itself produces NO in the mammal. Further disclosed herein are strategies for synthesizing such compounds, and methods for testing whether the combination compounds and compositions provide a desired benefit. Also disclosed herein are pharmaceutical compositions and formulations that combine a FLAP inhibitor and an NO modulator. Further described herein are methods for using such compositions and compounds for the treatment of diseases, conditions, and disorders in a mammal, including a human. Such treatment methods include the separate administration of a FLAP inhibitor and a NO modulator to the mammal, and the simultaneous administration of a FLAP inhibitor and a NO modulator to the mammal.Type: ApplicationFiled: November 30, 2007Publication date: March 18, 2010Inventors: John H. Hutchinson, Mustapha Haddach, Mark Moran, Jillian Evans, Nicholas Simon Stock, Jeffrey Roger Roppe
-
Publication number: 20100061959Abstract: Methods and pharmaceutical compositions for providing neuroprotection to the animal central nervous system against the effects of ischemia, and neurodegeneration. Patients at risk for certain diseases or disorders that are associated with cerebral ischemia may benefit, e.g., those at risk for Alzheimer's disease, Parkinson's disease, Wilson's disease or stroke or those patients having head or spinal cord injury. Patients undergoing certain medical procedures that may result in ischemia may also benefit. Initially, the possibility of ischemia or neurodegeneration is recognized. Intranasal therapeutic agents are administered to the upper third of the nasal cavity to bypass the blood-brain barrier and access the central nervous system directly to avoid unwanted and potentially lethal side effects. Therapeutic agents include those substances that interact with iron and/or copper such as iron chelators and copper chelators. A particular example of such therapeutic agents is the iron chelator deferoxamine (DFO).Type: ApplicationFiled: November 16, 2009Publication date: March 11, 2010Applicant: HealthPartners Research FoundationInventors: William H. Frey II, Samuel Scott Panter, Leah Ranae Bresin Hanson
-
Publication number: 20100055200Abstract: The present invention discloses a composition that contains (1) an effective amount of an analgesically and/or anti-inflammatory active fraction separated from a mixture of plasma and/or serum, and (2) at least one metal, metal ion or metal salt, in which the mixture has been denatured. Also disclosed are methods of producing the composition for treating a subject afflicted with inflammation and/or pain.Type: ApplicationFiled: March 31, 2009Publication date: March 4, 2010Applicant: CAMBRIDGE SCIENTIFIC PTY LTD, an Australian corporationInventors: Jeffrey D. Edwards, John Palermo